治療頭暈 Asthma, chronic; Adjunct, Cerebrovascular disease, Disorder of skin, Motion sickness; Prophylaxis, Peripheral vascular disease, Vertigo (Non US FDA approved)

Cinnarizine is a piperazine derivative, H1 histamine antagonist.

Prior history of hypersensitivity to cinnarizine or any of its components.

Fetal risk cannot be ruled out.

Infant risk cannot be ruled out.

Weight gain, gastrointestinal disorders, epigastric pain, nausea, and vomiting, liver function abnormalities, systemic lupus erythematosus, transient fatigue and drowsiness, dizziness, asthenia and headache, extrapyramidal symptoms such as tremor, rigor, and hypokinesia. tinnitus.

The usual initial dose for adult patients with vestibular disorders is 75 milligrams (mg) once or twice daily, followed by a maintenance dose of 75 mg once daily.